11 Recruiting Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Related Conditions
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (7)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (5)Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (4)Head and Neck Squamous Cell Carcinoma (3)Stage III Hypopharyngeal Carcinoma AJCC v8 (3)Stage III Laryngeal Cancer AJCC v8 (3)Stage IVA Laryngeal Cancer AJCC v8 (3)
Top Recruiting Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Studies
🔵 Active, Not Recruiting Phase2 📋 Clinical Research Protocol
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer
📍 Emory University Midtown Hospital — Atlanta, Georgia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
📍 Tower Cancer Research Foundation — Beverly Hills, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
📍 Arizona Center for Cancer Care - Gilbert — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 🩺 Clinical Procedure Protocol
Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
📍 Emory University Hospital Midtown — Atlanta, Georgia
View Study & Checklist ➔